{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:09:43Z","timestamp":1765728583078},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.clinthera.2016.03.027","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T10:23:16Z","timestamp":1461925396000},"page":"1074-1080","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population"],"prefix":"10.1016","volume":"38","author":[{"given":"Ankita","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Michael Lewiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Papadopoulos Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.03.027_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.amjopharm.2008.12.002","article-title":"Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions","volume":"6","author":"Teschemaker","year":"2008","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.clinthera.2016.03.027_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1185\/03007995.2013.851074","article-title":"Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis","volume":"30","author":"Siris","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2016.03.027_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"Cramer","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2016.03.027_bib4","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1517\/14656560903140533","article-title":"Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence","volume":"10","author":"Rabenda","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"2 Suppl","key":"10.1016\/j.clinthera.2016.03.027_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.12.002","article-title":"Impact of osteoporosis treatment adherence on fracture rates in North America and Europe","volume":"122","author":"Siris","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2016.03.027_bib6","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2009-2778","article-title":"The complex relation between bisphosphonate adherence and fracture reduction","volume":"95","author":"Patrick","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2016.03.027_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.18553\/jmcp.2011.17.1.25","article-title":"The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis","volume":"17","author":"Halpern","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinthera.2016.03.027_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00002512-200724010-00003","article-title":"Patient adherence to osteoporosis medications: problems, consequences and management strategies","volume":"24","author":"Papaioannou","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2016.03.027_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2474-15-112","article-title":"Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries","volume":"15","author":"Yun","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clinthera.2016.03.027_bib10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00198-006-0073-6","article-title":"Determinants of adherence to osteoporosis treatment in clinical practice","volume":"17","author":"Rossini","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2016.03.027_bib11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1185\/030079908X297358","article-title":"Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis","volume":"24","author":"Penning-van Beest","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2016.03.027_bib12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1359\/jbmr.080510","article-title":"Fracture outcomes related to persistence and compliance with oral bisphosphonates","volume":"23","author":"Gallagher","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2016.03.027_bib13","first-page":"499","article-title":"Association between gastrointestinal events and persistence with osteoporosis therapy: analysis of administrative claims of a U.S. Managed care population","volume":"21","author":"Modi","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2016.03.027_bib14","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.clinthera.2015.03.018","article-title":"Gastrointestinal Events Among Patients Initiating Osteoporosis Therapy: A Retrospective Administrative Claims Database Analysis","volume":"37","author":"Modi","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2016.03.027_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1345\/aph.1L555","article-title":"Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate","volume":"43","author":"Blumentals","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2016.03.027_bib16","first-page":"S207","article-title":"Incidence of gastrointestinal events among bisphosphonate patients in an observational setting","volume":"10","author":"Miller","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2016.03.027_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","article-title":"Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study","volume":"3","author":"Camilleri","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2016.03.027_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1745-7599.2008.00316.x","article-title":"The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women","volume":"20","author":"Infantino","year":"2008","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.clinthera.2016.03.027_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2474-11-68","article-title":"Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study","volume":"11","author":"Grima","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clinthera.2016.03.027_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00296-009-0940-5","article-title":"Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis","volume":"30","author":"Ringe","year":"2009","journal-title":"Rheumatol Int"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816301643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816301643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T01:36:57Z","timestamp":1656207417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816301643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0149291816301643"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.03.027","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}